Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ANKRD50 |
| Upstream (Parents) |
|---|
| (<<) HLA-F → ANKRD50 |
| (<<) BCL2L14 → ANKRD50 |
| (<<) CACNA1D → ANKRD50 |
| (<<) PLA2G12A → ANKRD50 |
| (<<) LRBA → ANKRD50 |
| (<<) APBB2 → ANKRD50 |
| (<<) GAB1 → ANKRD50 |
| Downstream (Children) |
|---|
| ANKRD50 → USP53 (>>) |
| ANKRD50 → NPNT (>>) |
| ANKRD50 → MAGI3 (>>) |
| ANKRD50 → PLA2G12A (>>) |
| ANKRD50 → INTU (>>) |
| ANKRD50 → ZNF827 (>>) |
| ANKRD50 → LRBA (>>) |
